Styers Thomas J, Kekec Ahmet, Rodriguez Rodrigo, Brown Joseph D, Cajica Julia, Pan Po-Shen, Parry Emily, Carroll Chris L, Medina Irene, Corral Ricardo, Lapera Stephanie, Otrubova Katerina, Pan Chung-Mao, McGuire Kathleen L, McAlpine Shelli R
Department of Chemistry and Biochemistry, San Diego State University, CA 92182-1030, USA.
Bioorg Med Chem. 2006 Aug 15;14(16):5625-31. doi: 10.1016/j.bmc.2006.04.031. Epub 2006 May 11.
We report the synthesis of thirty-six Sansalvamide A derivatives, and their biological activity against colon cancer HT-29 cell line, a microsatellite stable (MSS) colon cancer cell-line. The thirty-six compounds can be divided into three subsets, where the first subset of compounds contains L-amino acids, the second subset contains D-amino acids, and the third subset contains both D- and L-amino acids. Five compounds exhibited excellent inhibitory activity (>75% inhibition). The structure-activity relationship (SAR) of the compounds established that a single D-amino acid in position 2 or 3 gave up to a 10-fold improved cytotoxicity over Sansalvamide A peptide. This work highlights the importance of residues 2 and 3 and the role of D-amino acids in the extraordinary SAR for this compound class.
我们报道了三十六种Sansalvamide A衍生物的合成及其对结肠癌HT-29细胞系(一种微卫星稳定(MSS)的结肠癌细胞系)的生物活性。这三十六种化合物可分为三个子集,其中第一子集的化合物含有L-氨基酸,第二子集含有D-氨基酸,第三子集同时含有D-和L-氨基酸。五种化合物表现出优异的抑制活性(抑制率>75%)。化合物的构效关系(SAR)表明,在第2或3位的单个D-氨基酸比Sansalvamide A肽的细胞毒性提高了10倍。这项工作突出了第2和3位残基的重要性以及D-氨基酸在这类化合物非凡SAR中的作用。